Description
BSE announces the forthcoming listing of equity shares of Gaudium IVF and Women Health Limited (scrip code 544709, symbol GAUDIUMIVF). The exact listing date will be communicated via a separate notice.
Summary
BSE has notified trading members that the equity shares of Gaudium IVF and Women Health Limited will be listed and admitted to dealings on the Exchange. The exact listing date and further security details will be communicated through a separate notice.
Key Points
- Company: Gaudium IVF and Women Health Limited
- Scrip Code: 544709
- Symbol: GAUDIUMIVF
- ISIN: INE0P8B01020
- Segment: Equity
- Listing date to be announced via a separate notice
Regulatory Changes
No regulatory changes. This is a standard new listing admission notice under BSE’s listing procedures.
Compliance Requirements
Trading members should note the scrip details and await the follow-up notice from BSE confirming the exact listing date and additional security information before initiating trades.
Important Dates
- Notice Date: February 26, 2026
- Listing Date: To be announced via a separate notice
Impact Assessment
This circular has moderate market impact as it signals the imminent listing of a new equity on BSE in the healthcare/fertility services sector. Traders and investors interested in the IVF and women’s health space should track the follow-up listing date announcement. No immediate trading action is required until the listing date notice is issued.
Impact Justification
Routine new equity listing notice for a healthcare company; specific listing date not yet confirmed, limiting immediate actionability, but relevant for traders and investors tracking new listings.